Dominican Republic vs Vanuatu: Statin use vs. average non-HDL cholesterol levels
Dominican Republic
3.6
in 2018
Vanuatu
3.6
in 2018
Dominican Republic rank
30th
Vanuatu rank
30th
Statin use vs. average non-HDL cholesterol levels over time
- Dominican Republic
- Vanuatu
How they compare
Dominican Republic currently reports 3.6 against 3.6 in Vanuatu, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Dominican Republic ahead.
Dominican Republic ranks 30th and Vanuatu ranks 30th of 191 countries.
Across the 4 decades both report, Dominican Republic averaged higher in 1 and Vanuatu in 3.
Head to head by decade
| Decade | Dominican Republic | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.4 | 3.32 | 0.08 | Dominican Republic |
| 1990s | 3.4 | 3.47 | 0.07 | Vanuatu |
| 2000s | 3.45 | 3.52 | 0.07 | Vanuatu |
| 2010s | 3.57 | 3.6 | 0.0333 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Dominican Republic or Vanuatu?
- Dominican Republic, at 3.6 against 3.6 in Vanuatu as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Dominican Republic and Vanuatu?
- 0, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Vanuatu?
- 39 years are reported by both, from 1980 to 2018.
- How do Dominican Republic and Vanuatu rank globally for statin use vs. average non-hdl cholesterol levels?
- Dominican Republic ranks 30th and Vanuatu ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.